Amphastar Pharmaceuticals, Inc. (AMPH)

NASDAQ: AMPH · Real-Time Price · USD

23.18

0.00 (0.00%)

Sep 4, 2026, 4:00 PM EDT - Market closed

Amphastar Pharmaceuticals Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	730.02	719.89	731.97	644.4	498.99	437.77
Revenue Growth	1.02%	-1.65%	13.59%	29.14%	13.98%	25.13%
Gross Profit	348.11	356.06	373.86	351.12	248.86	199.74
Operating Income	137.39	163.5	205.42	196.99	107.5	71.69
Net Income	78.55	98.09	159.52	137.55	91.39	62.12
Earnings Per Share	1.69	2.03	3.06	2.60	1.74	1.25
EPS Growth	-37.04%	-33.66%	17.69%	49.43%	39.20%	4090.97%

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
United States	683.21	681.42	707.68	635.19	486.83	419.87
China	9.85	3.18	4.34	4.51	4.7	6.02
France	36.96	35.28	19.95	4.7	7.46	11.88
Total	730.02	719.89	731.97	644.4	498.99	437.77

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	290.12	282.81	221.65	256.81	175.76	136.67
Total Debt	688.32	656	650.55	623.64	102.58	104.66
Net Cash (Debt)	-398.2	-373.19	-428.9	-366.84	73.18	32.01
Net Cash Growth	-	-	-	-	128.62%	-16.53%
Net Cash Per Share	-8.59	-7.74	-8.24	-6.92	1.40	0.64

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	184.61	156.12	213.39	183.5	89.18	97.99
Capital Expenditures	-31.72	-34.88	-41.04	-38.17	-24.03	-27.46
Free Cash Flow	152.89	121.23	172.35	145.34	65.15	70.54
Free Cash Flow Growth	36.28%	-29.66%	18.58%	123.09%	-7.64%	201.30%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	47.69%	49.46%	51.08%	54.49%	49.87%	45.63%
Operating Margin	18.82%	22.71%	28.06%	30.57%	21.54%	16.38%
Pretax Margin	13.98%	17.17%	25.85%	26.28%	23.02%	19.17%
Profit Margin	10.76%	13.63%	21.79%	21.34%	18.31%	14.19%
FCF Margin	20.94%	16.84%	23.54%	22.55%	13.06%	16.11%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	13.74	12.55	11.19	21.54	14.82	17.94
Forward PE	7.29	7.78	9.42	20.77	16.29	16.96
P/FCF Ratio	6.45	10.15	10.36	20.39	20.79	15.80
PS Ratio	1.35	1.71	2.44	4.60	2.71	2.55